Back
Speaker illustration

Assistant Professor Lokman Hekim Tanriverdi

Inonu University, Malatya (Türkiye)

Member of:

European Society of Cardiology

Dr. Tanriverdi graduated from Inonu University Faculty of Medicine in 2016 and received PhD in Medical Pharmacology from the Institute of Health Sciences at Inonu University in 2021. He held a postdoctoral fellow position at the Aortic Institute at Yale-New Haven Hospital in 2022, focusing on research synthesis of the medical management of thoracic aortic aneurysm disease. His research interests include research synthesis, clinical pharmacology, drug-drug interactions, clinical trials, risk of bias, systematic review and meta-analysis of interventions, and the GRADE approach. Additionally, Dr. Tanriverdi is on the Editorial Board of the journal Cell Biochemistry & Function; he is serving as the secretary of the Executive Committee of the Clinical Pharmacology WG of the Turkish Pharmacological Society and is also a member of the International Lipid and Blood Pressure Meta-Analysis Collaboration Group and the European Society of Cardiology Cardiovascular Pharmacotherapy (EuroCVP) WG.

Presentations

Efficacy of beta blockers in patients with thoracic aortic aneurysm: meta-analysis of randomized controlled trials

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Mechanisms of thoracic aortic disease and their treatment

Access
Thumbnail

Vericiguat in heart failure patients: analyzing safety, tolerability, and quality of life via meta-analysis of randomized controlled trials

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Heart failure: drug therapy and multidisciplinary care

Access
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources